ABOUT THIS EVENT

Inventiva S.A (Nasdaq: IVA), (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, rings the Nasdaq Closing Bell remotely from across the country.

Frédéric Cren, CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.